HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS/FDA open Indian offices

This article was originally published in The Tan Sheet

Executive Summary

Health and Human Services Secretary Mike Leavitt and FDA Commissioner Andrew von Eschenbach announce Jan. 15 the agencies have offices established in New Delhi, and Mumbai, India. Ten HHS/FDA officials will be assigned in India "to work closely with industries that ship food and medical products to the United States, to improve safety and quality, which will facilitate the smooth flow of trade," HHS says. FDA also has a presence in China, Central America and Europe. As part of its Beyond Our Borders Initiative, the agency says it will expand in 2009 to Mexico, the Middle East and South America and open additional European sites (1"The Tan Sheet" Jan. 28, 2008, p. 3)

You may also be interested in...



FDA Eyes Five Global Regions For Permanent Outposts – Commissioner

FDA is in the early stages of developing "boots on the ground" programs in five regions overseas in an effort to improve the quality of imported products at their source, Commissioner Andrew von Eschenbach said Jan. 24 at a media briefing on food safety issues

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.

CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales

Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS136224

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel